CENTANNI, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 36
AS - Asia 28
EU - Europa 27
Continente sconosciuto - Info sul continente non disponibili 1
Totale 92
Nazione #
US - Stati Uniti d'America 36
SG - Singapore 25
IT - Italia 23
GB - Regno Unito 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
DE - Germania 1
HK - Hong Kong 1
NL - Olanda 1
PK - Pakistan 1
Totale 92
Città #
Singapore 12
Santa Clara 11
Milan 8
Chicago 3
Lawrence 3
Muggiò 3
Princeton 3
Rome 3
Assago 2
Campobasso 2
Des Moines 2
London 2
New York 2
Palermo 2
San Nicola Manfredi 2
Dubai 1
Hong Kong 1
Legnago 1
Munich 1
Wilmington 1
Totale 65
Nome #
Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis 15
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 14
ChAracterization of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab in a real-life setting: the observational rEtrospective ANANKE study 12
Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study 11
Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19? 10
Clinical Features and Efficacy of Benralizumab in Patients with Blood Eosinophil Count Between 300 and 450 Cells/mm3: A Post Hoc Analysis from the ANANKE Study 9
Switching from one biologic to benralizumab in patients with severe eosinophilic asthma: An ANANKE study post hoc analysis 8
COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments 8
Point-of-Care Lung Sonography: An Audit of 1150 Examinations 7
Lung Ultrasound B Lines: Etiologies and Evolution with Age 6
Sustained Effectiveness of Benralizumab in Naïve and Biologics-Experienced Severe Eosinophilic Asthma Patients: Results from the ANANKE Study 5
Totale 105
Categoria #
all - tutte 2.330
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.330


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 0 0 1
2020/20212 0 2 0 0 0 0 0 0 0 0 0 0
2021/20228 0 0 0 0 0 0 2 2 0 1 3 0
2022/202310 6 0 0 1 1 1 0 1 0 0 0 0
2023/202425 5 1 3 0 0 5 1 2 0 3 5 0
2024/202559 16 2 3 1 2 13 14 5 1 2 0 0
Totale 105